Moreover, a significant difference in the expression level of HER-2 was also observed between CHBC and non-hereditary breast cancer patients (X2 = 11.55, P < 0.005), specifically with respect to the expression level of HER-2 (+++) (X2 = 11.56, P < 0.001). This evidence concerns the gene ERBB2 and breast carcinoma.